Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.

Some shift to save money in response to CVS Caremark restrictions; others appeal for Zepbound coverage, citing better weight-loss results By Peter Loftus Follow Updated July 27, 2025 10:57 am ET ...

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.

Zepbound is a prescription injection used for weight loss and weight management. Learn more about the best places to inject the drug and what a typical dosing schedule looks like.

The Zepbound LillyDirect offers comes in a single-dose vial rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available are 2.5 milligrams (mg) and 5 mg, which are ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

Actress/comedian Kym Whitley is having quite a July. Besides a featured role in “Happy Gilmore 2,” premiering in theaters July 25, she’s been named one of weight loss drug Zepbound’s first ...